Global Blood Glucose Device Market Insights, Forecast to 2028

Publisher Name :
Date: 28-Aug-2023
No. of pages: 88
Inquire Before Buying

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Blood Glucose Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Blood Glucose Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Blood Glucose Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Blood Glucose Device include Abbott Laboratories (U.S.), ARKRAY (Japan), Dexcom (U.S.), F.Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (U.S.), Medtronic (U.S.), Nipro Diagnostics (U.S.) and Terumo Medical Corporation (U.S.), etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Blood Glucose Device manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Blood Glucose Device market. Further, it explains the major drivers and regional dynamics of the global Blood Glucose Device market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Abbott Laboratories (U.S.)

- ARKRAY (Japan)

- Dexcom (U.S.)

- F.Hoffmann-La Roche Ltd (Switzerland)

- Johnson & Johnson (U.S.)

- Medtronic (U.S.)

- Nipro Diagnostics (U.S.)

- Terumo Medical Corporation (U.S.)

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Blood Glucose Device Segment by Type

- Blood Glucose Monitors

- Glucose Monitoring Strips

- Lancets

Blood Glucose Device Segment by Application

- Hospitals

- Diagnostics

- Home Settings

- Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Blood Glucose Device market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Blood Glucose Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Blood Glucose Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Blood Glucose Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Glucose Device sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Blood Glucose Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Blood Glucose Device sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott Laboratories (U.S.), ARKRAY (Japan), Dexcom (U.S.), F.Hoffmann-La Roche Ltd (Switzerland), Johnson & Johnson (U.S.), Medtronic (U.S.), Nipro Diagnostics (U.S.) and Terumo Medical Corporation (U.S.), etc.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Blood Glucose Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Blood Glucose Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.

Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Glucose Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.

Global Blood Glucose Device Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Blood Glucose Device Product Introduction
1.2 Market by Type
1.2.1 Global Blood Glucose Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Blood Glucose Monitors
1.2.3 Glucose Monitoring Strips
1.2.4 Lancets
1.3 Market by Application
1.3.1 Global Blood Glucose Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Diagnostics
1.3.4 Home Settings
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Blood Glucose Device Sales Estimates and Forecasts 2017-2028
2.2 Global Blood Glucose Device Revenue Estimates and Forecasts 2017-2028
2.3 Global Blood Glucose Device Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Blood Glucose Device Sales by Region
2.4.1 Global Blood Glucose Device Sales by Region (2017-2022)
2.4.2 Global Sales Blood Glucose Device by Region (2023-2028)
2.5 Global Blood Glucose Device Revenue by Region
2.5.1 Global Blood Glucose Device Revenue by Region (2017-2022)
2.5.2 Global Blood Glucose Device Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Blood Glucose Device Sales by Manufacturers
3.1.1 Global Top Blood Glucose Device Manufacturers by Sales (2017-2022)
3.1.2 Global Blood Glucose Device Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Blood Glucose Device in 2021
3.2 Global Blood Glucose Device Revenue by Manufacturers
3.2.1 Global Blood Glucose Device Revenue by Manufacturers (2017-2022)
3.2.2 Global Blood Glucose Device Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Blood Glucose Device Revenue in 2021
3.3 Global Blood Glucose Device Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Blood Glucose Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Blood Glucose Device Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Blood Glucose Device Sales by Type
4.1.1 Global Blood Glucose Device Historical Sales by Type (2017-2022)
4.1.2 Global Blood Glucose Device Forecasted Sales by Type (2023-2028)
4.1.3 Global Blood Glucose Device Sales Market Share by Type (2017-2028)
4.2 Global Blood Glucose Device Revenue by Type
4.2.1 Global Blood Glucose Device Historical Revenue by Type (2017-2022)
4.2.2 Global Blood Glucose Device Forecasted Revenue by Type (2023-2028)
4.2.3 Global Blood Glucose Device Revenue Market Share by Type (2017-2028)
4.3 Global Blood Glucose Device Price by Type
4.3.1 Global Blood Glucose Device Price by Type (2017-2022)
4.3.2 Global Blood Glucose Device Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Blood Glucose Device Sales by Application
5.1.1 Global Blood Glucose Device Historical Sales by Application (2017-2022)
5.1.2 Global Blood Glucose Device Forecasted Sales by Application (2023-2028)
5.1.3 Global Blood Glucose Device Sales Market Share by Application (2017-2028)
5.2 Global Blood Glucose Device Revenue by Application
5.2.1 Global Blood Glucose Device Historical Revenue by Application (2017-2022)
5.2.2 Global Blood Glucose Device Forecasted Revenue by Application (2023-2028)
5.2.3 Global Blood Glucose Device Revenue Market Share by Application (2017-2028)
5.3 Global Blood Glucose Device Price by Application
5.3.1 Global Blood Glucose Device Price by Application (2017-2022)
5.3.2 Global Blood Glucose Device Price Forecast by Application (2023-2028)
6 North America
6.1 North America Blood Glucose Device Market Size by Type
6.1.1 North America Blood Glucose Device Sales by Type (2017-2028)
6.1.2 North America Blood Glucose Device Revenue by Type (2017-2028)
6.2 North America Blood Glucose Device Market Size by Application
6.2.1 North America Blood Glucose Device Sales by Application (2017-2028)
6.2.2 North America Blood Glucose Device Revenue by Application (2017-2028)
6.3 North America Blood Glucose Device Market Size by Country
6.3.1 North America Blood Glucose Device Sales by Country (2017-2028)
6.3.2 North America Blood Glucose Device Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Blood Glucose Device Market Size by Type
7.1.1 Europe Blood Glucose Device Sales by Type (2017-2028)
7.1.2 Europe Blood Glucose Device Revenue by Type (2017-2028)
7.2 Europe Blood Glucose Device Market Size by Application
7.2.1 Europe Blood Glucose Device Sales by Application (2017-2028)
7.2.2 Europe Blood Glucose Device Revenue by Application (2017-2028)
7.3 Europe Blood Glucose Device Market Size by Country
7.3.1 Europe Blood Glucose Device Sales by Country (2017-2028)
7.3.2 Europe Blood Glucose Device Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Blood Glucose Device Market Size by Type
8.1.1 Asia Pacific Blood Glucose Device Sales by Type (2017-2028)
8.1.2 Asia Pacific Blood Glucose Device Revenue by Type (2017-2028)
8.2 Asia Pacific Blood Glucose Device Market Size by Application
8.2.1 Asia Pacific Blood Glucose Device Sales by Application (2017-2028)
8.2.2 Asia Pacific Blood Glucose Device Revenue by Application (2017-2028)
8.3 Asia Pacific Blood Glucose Device Market Size by Region
8.3.1 Asia Pacific Blood Glucose Device Sales by Region (2017-2028)
8.3.2 Asia Pacific Blood Glucose Device Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Blood Glucose Device Market Size by Type
9.1.1 Latin America Blood Glucose Device Sales by Type (2017-2028)
9.1.2 Latin America Blood Glucose Device Revenue by Type (2017-2028)
9.2 Latin America Blood Glucose Device Market Size by Application
9.2.1 Latin America Blood Glucose Device Sales by Application (2017-2028)
9.2.2 Latin America Blood Glucose Device Revenue by Application (2017-2028)
9.3 Latin America Blood Glucose Device Market Size by Country
9.3.1 Latin America Blood Glucose Device Sales by Country (2017-2028)
9.3.2 Latin America Blood Glucose Device Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Blood Glucose Device Market Size by Type
10.1.1 Middle East and Africa Blood Glucose Device Sales by Type (2017-2028)
10.1.2 Middle East and Africa Blood Glucose Device Revenue by Type (2017-2028)
10.2 Middle East and Africa Blood Glucose Device Market Size by Application
10.2.1 Middle East and Africa Blood Glucose Device Sales by Application (2017-2028)
10.2.2 Middle East and Africa Blood Glucose Device Revenue by Application (2017-2028)
10.3 Middle East and Africa Blood Glucose Device Market Size by Country
10.3.1 Middle East and Africa Blood Glucose Device Sales by Country (2017-2028)
10.3.2 Middle East and Africa Blood Glucose Device Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott Laboratories (U.S.)
11.1.1 Abbott Laboratories (U.S.) Corporation Information
11.1.2 Abbott Laboratories (U.S.) Overview
11.1.3 Abbott Laboratories (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Laboratories (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Laboratories (U.S.) Recent Developments
11.2 ARKRAY (Japan)
11.2.1 ARKRAY (Japan) Corporation Information
11.2.2 ARKRAY (Japan) Overview
11.2.3 ARKRAY (Japan) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 ARKRAY (Japan) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 ARKRAY (Japan) Recent Developments
11.3 Dexcom (U.S.)
11.3.1 Dexcom (U.S.) Corporation Information
11.3.2 Dexcom (U.S.) Overview
11.3.3 Dexcom (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dexcom (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dexcom (U.S.) Recent Developments
11.4 F.Hoffmann-La Roche Ltd (Switzerland)
11.4.1 F.Hoffmann-La Roche Ltd (Switzerland) Corporation Information
11.4.2 F.Hoffmann-La Roche Ltd (Switzerland) Overview
11.4.3 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 F.Hoffmann-La Roche Ltd (Switzerland) Recent Developments
11.5 Johnson & Johnson (U.S.)
11.5.1 Johnson & Johnson (U.S.) Corporation Information
11.5.2 Johnson & Johnson (U.S.) Overview
11.5.3 Johnson & Johnson (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson (U.S.) Recent Developments
11.6 Medtronic (U.S.)
11.6.1 Medtronic (U.S.) Corporation Information
11.6.2 Medtronic (U.S.) Overview
11.6.3 Medtronic (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Medtronic (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Medtronic (U.S.) Recent Developments
11.7 Nipro Diagnostics (U.S.)
11.7.1 Nipro Diagnostics (U.S.) Corporation Information
11.7.2 Nipro Diagnostics (U.S.) Overview
11.7.3 Nipro Diagnostics (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Nipro Diagnostics (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Nipro Diagnostics (U.S.) Recent Developments
11.8 Terumo Medical Corporation (U.S.)
11.8.1 Terumo Medical Corporation (U.S.) Corporation Information
11.8.2 Terumo Medical Corporation (U.S.) Overview
11.8.3 Terumo Medical Corporation (U.S.) Blood Glucose Device Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Terumo Medical Corporation (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Terumo Medical Corporation (U.S.) Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Blood Glucose Device Industry Chain Analysis
12.2 Blood Glucose Device Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Blood Glucose Device Production Mode & Process
12.4 Blood Glucose Device Sales and Marketing
12.4.1 Blood Glucose Device Sales Channels
12.4.2 Blood Glucose Device Distributors
12.5 Blood Glucose Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Blood Glucose Device Industry Trends
13.2 Blood Glucose Device Market Drivers
13.3 Blood Glucose Device Market Challenges
13.4 Blood Glucose Device Market Restraints
14 Key Findings in The Global Blood Glucose Device Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Blood Glucose Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Blood Glucose Monitors
Table 3. Major Manufacturers of Glucose Monitoring Strips
Table 4. Major Manufacturers of Lancets
Table 5. Global Blood Glucose Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Blood Glucose Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Blood Glucose Device Sales by Region (2017-2022) & (K Units)
Table 8. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
Table 9. Global Blood Glucose Device Sales by Region (2023-2028) & (K Units)
Table 10. Global Blood Glucose Device Sales Market Share by Region (2023-2028)
Table 11. Global Blood Glucose Device Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Blood Glucose Device Revenue Market Share by Region (2017-2022)
Table 13. Global Blood Glucose Device Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Blood Glucose Device Revenue Market Share by Region (2023-2028)
Table 15. Global Blood Glucose Device Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Blood Glucose Device Sales Share by Manufacturers (2017-2022)
Table 17. Global Blood Glucose Device Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Blood Glucose Device Revenue Share by Manufacturers (2017-2022)
Table 19. Blood Glucose Device Price by Manufacturers (2017-2022) &(USD/Unit)
Table 20. Global Blood Glucose Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Blood Glucose Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood Glucose Device as of 2021)
Table 22. Blood Glucose Device Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Blood Glucose Device Product Offered
Table 24. Date of Manufacturers Enter into Blood Glucose Device Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 27. Global Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 28. Global Blood Glucose Device Sales Share by Type (2017-2022)
Table 29. Global Blood Glucose Device Sales Share by Type (2023-2028)
Table 30. Global Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Blood Glucose Device Revenue Share by Type (2017-2022)
Table 33. Global Blood Glucose Device Revenue Share by Type (2023-2028)
Table 34. Blood Glucose Device Price by Type (2017-2022) & (USD/Unit)
Table 35. Global Blood Glucose Device Price Forecast by Type (2023-2028) & (USD/Unit)
Table 36. Global Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 37. Global Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 38. Global Blood Glucose Device Sales Share by Application (2017-2022)
Table 39. Global Blood Glucose Device Sales Share by Application (2023-2028)
Table 40. Global Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Blood Glucose Device Revenue Share by Application (2017-2022)
Table 43. Global Blood Glucose Device Revenue Share by Application (2023-2028)
Table 44. Blood Glucose Device Price by Application (2017-2022) & (USD/Unit)
Table 45. Global Blood Glucose Device Price Forecast by Application (2023-2028) & (USD/Unit)
Table 46. North America Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 47. North America Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 48. North America Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 51. North America Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 52. North America Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 55. North America Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 56. North America Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 59. Europe Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 60. Europe Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 63. Europe Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 64. Europe Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 67. Europe Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 68. Europe Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Blood Glucose Device Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Blood Glucose Device Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Blood Glucose Device Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Blood Glucose Device Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Blood Glucose Device Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Blood Glucose Device Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Blood Glucose Device Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Blood Glucose Device Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Blood Glucose Device Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Blood Glucose Device Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Blood Glucose Device Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Blood Glucose Device Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Blood Glucose Device Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Blood Glucose Device Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Blood Glucose Device Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Blood Glucose Device Revenue by Country (2023-2028) & (US$ Million)
Table 106. Abbott Laboratories (U.S.) Corporation Information
Table 107. Abbott Laboratories (U.S.) Description and Major Businesses
Table 108. Abbott Laboratories (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 109. Abbott Laboratories (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Abbott Laboratories (U.S.) Recent Developments
Table 111. ARKRAY (Japan) Corporation Information
Table 112. ARKRAY (Japan) Description and Major Businesses
Table 113. ARKRAY (Japan) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 114. ARKRAY (Japan) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. ARKRAY (Japan) Recent Developments
Table 116. Dexcom (U.S.) Corporation Information
Table 117. Dexcom (U.S.) Description and Major Businesses
Table 118. Dexcom (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 119. Dexcom (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Dexcom (U.S.) Recent Developments
Table 121. F.Hoffmann-La Roche Ltd (Switzerland) Corporation Information
Table 122. F.Hoffmann-La Roche Ltd (Switzerland) Description and Major Businesses
Table 123. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 124. F.Hoffmann-La Roche Ltd (Switzerland) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. F.Hoffmann-La Roche Ltd (Switzerland) Recent Developments
Table 126. Johnson & Johnson (U.S.) Corporation Information
Table 127. Johnson & Johnson (U.S.) Description and Major Businesses
Table 128. Johnson & Johnson (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 129. Johnson & Johnson (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. Johnson & Johnson (U.S.) Recent Developments
Table 131. Medtronic (U.S.) Corporation Information
Table 132. Medtronic (U.S.) Description and Major Businesses
Table 133. Medtronic (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 134. Medtronic (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Medtronic (U.S.) Recent Developments
Table 136. Nipro Diagnostics (U.S.) Corporation Information
Table 137. Nipro Diagnostics (U.S.) Description and Major Businesses
Table 138. Nipro Diagnostics (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 139. Nipro Diagnostics (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Nipro Diagnostics (U.S.) Recent Developments
Table 141. Terumo Medical Corporation (U.S.) Corporation Information
Table 142. Terumo Medical Corporation (U.S.) Description and Major Businesses
Table 143. Terumo Medical Corporation (U.S.) Blood Glucose Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 144. Terumo Medical Corporation (U.S.) Blood Glucose Device Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Terumo Medical Corporation (U.S.) Recent Developments
Table 146. Key Raw Materials Lists
Table 147. Raw Materials Key Suppliers Lists
Table 148. Blood Glucose Device Distributors List
Table 149. Blood Glucose Device Customers List
Table 150. Blood Glucose Device Market Trends
Table 151. Blood Glucose Device Market Drivers
Table 152. Blood Glucose Device Market Challenges
Table 153. Blood Glucose Device Market Restraints
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Blood Glucose Device Product Picture
Figure 2. Global Blood Glucose Device Market Share by Type in 2021 & 2028
Figure 3. Blood Glucose Monitors Product Picture
Figure 4. Glucose Monitoring Strips Product Picture
Figure 5. Lancets Product Picture
Figure 6. Global Blood Glucose Device Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Diagnostics
Figure 9. Home Settings
Figure 10. Others
Figure 11. Blood Glucose Device Report Years Considered
Figure 12. Global Blood Glucose Device Sales 2017-2028 (K Units)
Figure 13. Global Blood Glucose Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Blood Glucose Device Revenue 2017-2028 (US$ Million)
Figure 15. Global Blood Glucose Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Blood Glucose Device Sales Market Share by Region (2017-2022)
Figure 17. Global Blood Glucose Device Sales Market Share by Region (2023-2028)
Figure 18. North America Blood Glucose Device Sales YoY (2017-2028) & (K Units)
Figure 19. North America Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Blood Glucose Device Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Blood Glucose Device Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Blood Glucose Device Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Blood Glucose Device Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Blood Glucose Device Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Blood Glucose Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Blood Glucose Device in the World: Market Share by Blood Glucose Device Revenue in 2021
Figure 30. Global Blood Glucose Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Blood Glucose Device Sales Market Share by Type (2017-2028)
Figure 32. Global Blood Glucose Device Revenue Market Share by Type (2017-2028)
Figure 33. Global Blood Glucose Device Sales Market Share by Application (2017-2028)
Figure 34. Global Blood Glucose Device Revenue Market Share by Application (2017-2028)
Figure 35. North America Blood Glucose Device Sales Market Share by Type (2017-2028)
Figure 36. North America Blood Glucose Device Revenue Market Share by Type (2017-2028)
Figure 37. North America Blood Glucose Device Sales Market Share by Application (2017-2028)
Figure 38. North America Blood Glucose Device Revenue Market Share by Application (2017-2028)
Figure 39. North America Blood Glucose Device Sales Share by Country (2017-2028)
Figure 40. North America Blood Glucose Device Revenue Share by Country (2017-2028)
Figure 41. U.S. Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Blood Glucose Device Sales Market Share by Type (2017-2028)
Figure 44. Europe Blood Glucose Device Revenue Market Share by Type (2017-2028)
Figure 45. Europe Blood Glucose Device Sales Market Share by Application (2017-2028)
Figure 46. Europe Blood Glucose Device Revenue Market Share by Application (2017-2028)
Figure 47. Europe Blood Glucose Device Sales Share by Country (2017-2028)
Figure 48. Europe Blood Glucose Device Revenue Share by Country (2017-2028)
Figure 49. Germany Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 50. France Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Blood Glucose Device Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Blood Glucose Device Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Blood Glucose Device Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Blood Glucose Device Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Blood Glucose Device Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Blood Glucose Device Revenue Share by Region (2017-2028)
Figure 60. China Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 63. India Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 65. Taiwan Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 69. Philippines Blood Glucose Device Revenue (2017-2028) & (US$ Million)
Figure 70. Latin America Blood Glucose Device Sales Market Share by Type (2017-2028)
Figure 71. Latin America Blood Glucose Device Revenue Market Share by Type (2017-2028)
Figure 72. Latin America Blood Glucose Device Sales Market Share by Application (2017-2028)
Figure 73. Latin America Blood Glucose Device Revenue Market Share by Application (2017-2028)
Figure 74. Latin America Blood Glucose Device Sales Share by Country (2017-202
  • Global Non-Invasive Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 79
    This report studies The Non-Invasive Glucose Meter market. Noninvasive glucose monitoring refers to The measurement of blood glucose levels (required by people with diabetes to prevent both chronic and acute complications from The disease) without drawing blood, puncturing The skin, or causing pain or trauma. The global Non-Invasive Glucose Meter market was valued at US$ 179.5 million in 2023 and is anticipated to reach US$ 271.2 million by 2030, witnessing a CAGR of 6.0% during The......
  • Global Glucose Meter Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 106
    Glucose Meter is a medical device for determining The approximate concentration of glucose in The blood. It can also be a strip of glucose paper dipped into a substance and measured to The glucose chart. It is a key element of home blood glucose monitoring (HBGM) by people with diabetes mellitus or hypoglycemia. A small drop of blood, obtained by pricking The skin with a lancet, is placed on a disposable test strip that The meter reads and uses to calculate The blood glucose level. The meter the......
  • Global Blood Glucose Testing Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 101
    Blood glucose testing, also known as blood glucose monitoring, is one of The main tools involved in controlling diabetes. Blood glucose testing is The process used to measure The concentration of glucose in your blood. Blood glucose testing can be carried out at home using a blood glucose meter. A blood test involves pricking your finger with a small needle called a lancet, drawing a drop of blood from The finger and applying it to a test strip that has been engaged into a blood gluc......
  • Global Glucose Biosensors Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 139
    According to our LPI (LP Information) latest study, the global Glucose Biosensors market size was valued at US$ 3249.7 million in 2023. With growing demand in downstream market, the Glucose Biosensors is forecast to a readjusted size of US$ 3620.7 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential of the global Glucose Biosensors market. Glucose Biosensors are expected to show stable growth in the future market. However, product ......
  • Global Artificial Pancreas Devices Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Artificial Pancreas Devices Systems market size was valued at US$ 87 million in 2023. With growing demand in downstream market, the Artificial Pancreas Devices Systems is forecast to a readjusted size of US$ 199.2 million by 2030 with a CAGR of 12.6% during review period. The research report highlights the growth potential of the global Artificial Pancreas Devices Systems market. Artificial Pancreas Devices Systems are expect......
  • Global Blood Glucose Testing Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 130
    According to our LPI (LP Information) latest study, the global Blood Glucose Testing market size was valued at US$ 10710 million in 2023. With growing demand in downstream market, the Blood Glucose Testing is forecast to a readjusted size of US$ 13370 million by 2030 with a CAGR of 3.2% during review period. The research report highlights the growth potential of the global Blood Glucose Testing market. Blood Glucose Testing are expected to show stable growth in the future market. However......
  • Global Lancing Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Lancing Devices market size was valued at US$ 315 million in 2023. With growing demand in downstream market, the Lancing Devices is forecast to a readjusted size of US$ 439.6 million by 2030 with a CAGR of 4.9% during review period. The research report highlights the growth potential of the global Lancing Devices market. Lancing Devices are expected to show stable growth in the future market. However, product differentiation,......
  • Global Non-Invasive Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Non-Invasive Glucose Meter market size was valued at US$ 175.6 million in 2023. With growing demand in downstream market, the Non-Invasive Glucose Meter is forecast to a readjusted size of US$ 268 million by 2030 with a CAGR of 6.2% during review period. The research report highlights the growth potential of the global Non-Invasive Glucose Meter market. Non-Invasive Glucose Meter are expected to show stable growth in the futu......
  • Global Glucose Meter Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Glucose Meter market size was valued at US$ 1258 million in 2023. With growing demand in downstream market, the Glucose Meter is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Glucose Meter market. Glucose Meter are expected to show stable growth in the future market. However, product differentiation, reduc......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs